Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Tumor Necrosis Factor (TNF) blocking agents are associated with lower risk for Alzheimer’s disease in patients with rheumatoid arthritis and psoriasis

Fig 9

Effect of age, gender and race on risk for a diagnosis of dementia in rheumatoid arthritis patients treated with etanercept.

Young patients (18–65 years) showed greater benefit than did older patients (over 65 years). The effect of gender and race was not significant.

Fig 9

doi: https://doi.org/10.1371/journal.pone.0229819.g009